Effect of isosorbide mononitrate combined with metoprolol in the treatment of heart failure in patients with coronary heart disease
	    		
		   		
		   			 
		   		
	    	
    	 
    	10.3760/cma.j.issn.1008-6706.2019.05.003
   		
        
        	
        		- VernacularTitle:单硝酸异山梨酯联合美托洛尔治疗冠心病心力衰竭的疗效观察
- Author:
	        		
		        		
		        		
			        		Hongxia ZHU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Songbo DONG
			        		
			        		
		        		
		        		
		        		
    Author Information Author Information
 
			        		
			        		
			        			1. 浙江省
 
 
- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Coronary disease;
			        		
			        		
			        		
				        		Heart failure;
			        		
			        		
			        		
				        		Isosorbide mononitrate;
			        		
			        		
			        		
				        		Metoprolol
			        		
			        		
	        			
        			
        		
- From:
	            		
	            			Chinese Journal of Primary Medicine and Pharmacy
	            		
	            		 2019;26(5):523-526
	            	
            	
- CountryChina
- Language:Chinese
- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To observe the clinical effect of isosorbide mononitrate combined with metoprolol in the treatment of coronary heart failure.Methods From January 2015 to May 2017,100 patients with coronary heart failure treated in the Second People's Hospital of Yuyao were randomly divided into two groups according to the digital table,with 50 cases in each group.The conventional group was treated with conventional therapy.The observation group was treated with isosorbide mononitrate combined with metoprolol on the basis of conventional treatment for 30 days.The clinical efficacy,cardiac function index and plasma BNP level were compared between the two groups.Results The total effective rate of the observation group was 96.0% (48/50),which was higher than 78.0% (39/50) in the conventional group(x2 =7.161,P < 0.01).After treatment,the cardiac drainage index(CI) [(3.14 ± 0.53) L · min-1 · (m2)-1],cardiac output blood volume (CO) [(5.62 ± 0.95) L/min],each stroke volume (SV) [(79.24 ± 2.56) mL],left ventricular ejection fraction (LVEF) [(61.62 ± 4.95) %] in the observation group were better than those in the conventional group[(2.41 ±0.45) L · min-1 · (m2)-1,(4.79 ± 0.23) L/min,(72.30 ± 2.78)mL,(53.79 ±4.23)%,t =7.043,5.696,12.318,8.066,all P <0.05].The BNP level of the observation group was (172.17 ± 10.36) pg/mL,which was lower than (215.47 ± 12.48) pg/mL of the conventional group (t =17.908,P < 0.05).Conclusion The treatment of coronary heart failure with isosorbide mononitrate and metoprolol can improve the clinical effect and improve cardiac function.